(TCAF) T. Rowe Price Capital - NYSE
ETF Category: Large Blend | Exchange: NYSE (USA) | Market Cap: 7.022m USD | Total Return: 18.8% in 12m
Avg Turnover: 25.9M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The T. Rowe Price Capital Appreciation Equity ETF (TCAF) is an actively managed, non-diversified exchange-traded fund that primarily targets large-cap U.S. equities. Under normal market conditions, the fund allocates at least 80% of its net assets to equity securities, maintaining the flexibility to invest across various market capitalizations while concentrating on established industry leaders.
The fund’s strategy frequently results in significant weightings within the information technology and healthcare sectors. The information technology sector often relies on recurring revenue models through software-as-a-service (SaaS), while the healthcare sector is characterized by high research and development costs and defensive demand cycles. Investors can use ValueRay to further analyze how these sector concentrations impact overall portfolio risk.
Launched in June 2023, TCAF operates as a Large Blend fund, seeking to balance growth and value characteristics. Its non-diversified status allows the portfolio managers to take larger positions in high-conviction stocks compared to traditional diversified funds.
- S&P 500 performance drives management fees and asset base growth
- Portfolio concentration in technology and healthcare sectors increases volatility
- Active management alpha generation influences net capital inflows
- Investor rotation from passive to active ETFs impacts market share
As of June 20, 2026, the stock is trading at USD 40.38 with a total of 1,084,769 shares traded.
Over the past week, the price has changed by +1.41%,
over one month by +0.90%,
over three months by +11.89% and
over the past year by +18.84%.
T. Rowe Price Capital has no consensus analysts rating.